NSE
Akums Drugs and Pharmaceuticals LimitedAKUMS
Akums Drugs and Pharmaceuticals Limited is an Indian pharmaceutical company engaged in the manufacturing and distribution of various drug products.
| Key products | Pharmaceuticals, including generic drugs and formulations. |
|---|---|
| Geography | Primarily operates in India with a focus on domestic markets. |
| Competitors | Dr Reddy's Laboratories, Cipla Limited |
AI-generated overview — verify before relying on it.
Net institutional flow
+₹195 Cr
Institutional buyers
2 in / 1 out
High-impact filings
0 · tilt Neutral
Next corporate action
Dividend - Re 1 Per Share/Special Dividend - Rs 2 Per Share
ex 2026-07-03
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | AKUMSThis | +₹195 Cr | 5 | — | — | — | — |
| 2 | MTNL | +₹41.3 Cr | 331 | — | — | — | — |
| 3 | ATALREAL | +₹7 Cr | 367 | — | — | — | — |
| 4 | GATECH | +₹0.4 Cr | 298 | — | — | — | — |
| 5 | IRMENERGY | −₹2.2 Cr | 356 | — | — | — | — |
| 6 | QUADFUTURE | −₹9 Cr | 581 | — | — | — | — |
| 7 | MOBIKWIK | −₹150.9 Cr | 975 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
SWOT
Weaknesses
- • Limited product diversification
- • Dependent on a few key products
Opportunities
- • Potential for market expansion in rural areas
- • Increased focus on digital marketing and e-commerce
Threats
- • Rising raw material costs
- • Regulatory changes impacting pharmaceutical industry
AI-generated from our data — verify before relying on it.
- 2026-07-03ActionDividend - Re 1 Per Share/Special Dividend - Rs 2 Per ShareDividend
- 2026-06-16FilingNewspaper Advertisement- Information regarding 22nd AGM and Final & Special DividendCompliance
- 2026-06-10FilingIntimation of Schedule of the investor/analysts meetsInvestor Call
- 2026-06-09FilingAkums Drugs and Pharmaceuticals Limited has informed the Exchange about Schedule of meetInvestor Call
- 2025-12-22BulkBUY · ₹311.5 CrICICI PRUDENTIAL MUTUAL FUND
- 2025-12-22BulkSELL · ₹311.5 CrRUBY QC INVESTMENT HOLDINGS PTE.LTD.
- 2025-12-22BlockBUY · ₹311.5 CrICICI PRUDENTIAL MUTUAL FUND
- 2025-12-22BlockSELL · ₹311.5 CrRUBY QC INVESTMENT HOLDINGS PTE.LTD.
- 2024-08-06BulkBUY · ₹195 CrSMALLCAP WORLD FUND INC
- 2024-08-06NetDay net +₹195 Cr
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 1ComplianceNeutral
Newspaper Advertisement- Information regarding 22nd AGM and Final & Special Dividend
Source PDF → - 2
- 2
5 deals · 2024-08-06 → 2025-12-22
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2025-12-22 | ICICI PRUDENTIAL MUTUAL FUND | Institution | BUY | ₹311.5 Cr |
| 2025-12-22 | RUBY QC INVESTMENT HOLDINGS PTE.LTD. | Institution | SELL | ₹311.5 Cr |
| 2025-12-22 | ICICI PRUDENTIAL MUTUAL FUND | Institution | BUY | ₹311.5 Cr |
| 2025-12-22 | RUBY QC INVESTMENT HOLDINGS PTE.LTD. | Institution | SELL | ₹311.5 Cr |
| 2024-08-06 | SMALLCAP WORLD FUND INC | Institution | BUY | ₹195 Cr |
5 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
Results & transcripts
Financial results
None yet.
News & chatter on AKUMS
RSS News
0No recent news.
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.